ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

ClinicalTrials.gov ID: NCT00421031

Public ClinicalTrials.gov record NCT00421031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Efficacy and Safety Study of DVS-233 SR For Relief of Vasomotor Symptoms Associated With Menopause

Study identification

NCT ID
NCT00421031
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
540 participants

Conditions and interventions

Interventions

  • DVS-233 SR Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Not listed
Completion
Mar 31, 2004
Last update posted
Jan 10, 2007

2003 – 2004

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
39
Facility City State ZIP Site status
Not listed Montgomery Alabama 36116
Not listed Peoria Arizona 85345
Not listed San Diego California 92123
Not listed Stanford California 94143
Not listed Colorado Springs Colorado 80907
Not listed Newark Delaware 19713
Not listed Aventura Florida 33160
Not listed Fort Myers Florida 33990
Not listed Inverness Florida 34452
Not listed Miami Florida 33143
Not listed New Port Richey Florida 32701
Not listed Ocala Florida 34470
Not listed Orange City Florida 32763
Not listed Pinellas Park Florida 33781
Not listed Tampa Florida 33709
Not listed West Palm Beach Florida 33409
Not listed West Venice Florida 34285
Not listed Atlanta Georgia 30342
Not listed Savannah Georgia 31405
Not listed Newburgh Indiana 47630
Not listed Lexington Kentucky 40536
Not listed Shreveport Louisiana 71103
Not listed Portland Maine 04102
Not listed Chaska Minnesota 55387
Not listed Jackson Mississippi 39216
Not listed St Louis Missouri 63131
Not listed Billings Montana 59101
Not listed Las Vegas Nevada 89119
Not listed Reno Nevada 89509
Not listed Albuquerque New Mexico 87102
Not listed Albuquerque New Mexico 87131
Not listed Winston-Salem North Carolina 27103
Not listed Canton Ohio 44406
Not listed Cincinnati Ohio 45249
Not listed Cincinnati Ohio 45267
Not listed Portland Oregon 97201
Not listed Erie Pennsylvania 16502
Not listed Wexford Pennsylvania 15090
Not listed Greenville South Carolina 29605
Not listed San Antonio Texas 78229
Not listed Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00421031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2007 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00421031 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →